Human triallelic sites: evidence for a new mutational mechanism?
Most SNPs in the human genome are biallelic; however, there are some sites that are triallelic. We show here that there are approximately twice as many triallelic sites as we would expect by chance. This excess does not appear to be caused by natural selection or mutational hotspots. Instead we propose that a new mutation can induce another mutation either within the same individual or subsequently during recombination. We provide evidence for this model by showing that the rarer two alleles at triallelic sites tend to cluster on phylogenetic trees of human haplotypes. However, we find no association between the density of triallelic sites and the rate of recombination, which leads us to suggest that triallelic sites might be generated by the simultaneous production of two new mutations within the same individual on the same genetic background. Under this model we estimate that simultaneous mutation contributes approximately 3% of all distinct SNPs. We also show that there is a twofold excess of adjacent SNPs. Approximately half of these seem to be generated simultaneously since they have identical minor allele frequencies. We estimate that the mutation of adjacent nucleotides accounts for a little less than 1% of all SNPs.
Hodgkinson
Alan
A
Centre for the Study of Evolution, School of Life Sciences, University of Sussex, Brighton, BN1 9QG, United Kingdom. a.j.hodgkinson@sussex.ac.uk
Eyre-Walker
Adam
A
D000483:Alleles; D015894:Genome, Human / Q000235:genetics; D006801:Humans; D008957:Models, Genetic; D016296:Mutagenesis; D009154:Mutation; D020641:Polymorphism, Single Nucleotide; D011995:Recombination, Genetic; D012641:Selection, Genetic; D017422:Sequence Analysis, DNA